Abstract:Affinity chromatography technologies play an important role in the purification of antibodies. To prepare affinity materials, prior isolation and purification of affinity ligands are required before coupling onto solid supports, which is quite expensive and laborious in large-scale applications. In this study, a one-step approach which circumvents the ligand purification procedures was developed to fabricate affinity gel for purifying immunoglobulin G (IgG). A self-labeling tag, haloalkane dehalogenase, was fused to the C-terminal of an anti-Fc variable domain of the heavy chain of the heavy-chain antibody (AFV) which was isolated in previous work. The AFV binds to various sources of IgG and is highly thermal stable. The fusion protein, namely HAFV, was expressed in Escherichia coli as a soluble protein. The binding affinity of HAFV to the Fc region of IgG was characterized and compared with the untagged anti-Fc nanobody. Next, the HAFV was immobilized directly from the crude cell lysate of isopropylthio-β-D-galactoside (IPTG) induced E. coli. The effects of NaCl concentrations and pH on the capacity of the HAFV resin were investigated. In addition, the one-step coupled HAFV resin was compared with the AFV resin and commercial resins (Protein A and Protein G) by evaluating the static capacity and stability. Though the Protein A (8.34 ± 0.37 mg/ml) and Protein G (9.19 ± 0.28 mg/ml) showed higher static capacity, the static capacity of HAFV resin (8.21 ± 0.30 mg/ml) was better than that of the untagged AFV gel (6.48 ± 0.56 mg/ml). The recovery results calculated for the reusability and stability show that there is no significant difference between the results obtained for the HAFV gel with those of the untagged AFV gel and commercial Protein A and G. After stored at 37 ℃ for 7 days and recycled 10 times, the static capacity of HAFV gel remains above 78%. Our strategy is site-specific, cost-effective, reproducible, and has the potential to dramatically cut down the costs of affinity materials for IgG purification.

Capture and purification of an untagged nanobody by mixed weak cation chromatography and cation exchange chromatography

Caprylate as the albumin-selective modifier to improve IgG purification with hydrophobic charge-induction chromatography.

A Novel Twin‐column Continuous Chromatography Approach for Separation and Enrichment of Monoclonal Antibody Charge Variants

Evaluation of Magnetic Particles Modified with a Hydrophobic Charge-Induction Ligand for Antibody Capture.

An Engineered Peptide Tag-Specific Nanobody for Immunoaffinity Chromatography Application Enabling Efficient Product Recovery at Mild Conditions

Characterization and Comparison of Two Peptide-Tag Specific Nanobodies for Immunoaffinity Chromatography.

Characterization of a nanobody-epitope tag interaction and its application for receptor engineering

Streamlined on-column refolding and purification of nanobodies from inclusion bodies expressed as fusion proteins

One-step orientated immobilization of nanobodies and its application for immunoglobulin purification

Cytoplasmic Expression of Nanobodies with Formylglycine Generating Enzyme Tag and Conversion to a Bio-Orthogonal Aldehyde Group

High Performance Production Process Development and Scale-Up of an Anti-Tslp Nanobody.

Nanobody-Based High-Performance Immunosorbent for Selective Beta 2-Microglobulin Purification from Blood.

Nanobodies As Solubilization Chaperones for the Expression and Purification of Inclusion-Body Prone Proteins

Efficient Development of Nanobody-Based Affinity Chromatography for AAV8 Purification

Coordination-driven Reversible Surfaces with Site-Specifically Immobilized Nanobody for Dynamic Cancer Cell Capture and Release.

Site-Specific Modification of Single Domain Antibodies by Enzyme-Immobilized Magnetic Beads

Biomimetic Affinity Chromatography for Antibody Purification: Host Cell Protein Binding and Impurity Removal.

An Integrated Methodology for Quality Assessment of Therapeutic Antibodies with Potential Long Circulation Half-Life in Harvested Cell Culture Fluid Using FcRn Immobilized Hydrophilic Magnetic Graphene.

Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control

A nanobody-based strategy for rapid and scalable purification of human protein complexes

Economic optimization of antibody capture through Protein A affinity nanofiber chromatography